ADD2 p.Pro587Ala
c.1759C>G · VCV3495530
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0487 | likely benign |
|---|---|---|
| REVEL | 0.017 | moderately benign-leaning |
| SaProt | LLR -5.76 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -2.2 | GERP -5 |
| Regional constraint | o/e 0.94 | unconstrained · MANE · 9,574 bp · p 0.4 · regional, not allelic |
| Overall | ||
| CADD | 0.021 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ADD2
- Protein
- p.Pro587Ala
- Coding
- c.1759C>G
- MANE Select
- NM_001617
- Type
- single nucleotide variant
- Location
- chr2:70672989 (GRCh38)
- Gene constraint
- LOEUF 0.388 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 66.51
- Residue 587
- the 'disordered' region
Similar variants
- ADD2 p.Pro587Thr Likely benign ★ same residue
- ADD2 p.Asp28Asn Benign ★★ ⚠ same type
- ADD2 p.Glu335Asp Benign ★★ same type
- ADD2 p.Gly17Glu Benign ★★ same type
- ADD2 p.Ala150Val Uncertain significance ★ ⚠ same type
- ADD2 p.Ala232Gly Uncertain significance ★ ⚠ same type
- ADD2 p.Ala312Thr Uncertain significance ★ ⚠ same type
- ADD2 p.Ala418Pro Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/add2-p-pro587ala (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown